%PDF-1.7
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2017-06-15T12:03:31-05:00
2017-06-15T12:03:32-05:00
2017-06-15T12:03:32-05:00
Adobe InDesign CC 2017 (Windows)
uuid:9f10665b-7f12-4037-a279-19d63aac30a5
xmp.did:5e04fea8-b29b-c643-9d13-a71790cd99a6
xmp.id:e1dc7769-8660-de40-acf9-7e8a68947b32
proof:pdf
xmp.iid:4c74f412-fb10-e34d-a052-958099cef5a1
xmp.did:b3a9abe6-6576-2348-9c06-0550fb4335f3
xmp.did:5e04fea8-b29b-c643-9d13-a71790cd99a6
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 2017 (Windows)
/
2017-06-15T12:03:31-05:00
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
5 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
11 0 obj
<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
14 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
32 0 obj
<>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
BT
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
0.04 Tc -0.04 Tw 9 0 0 9 529.2283 32.9076 Tm
(29)Tj
0 Tc 0.384 Tw 8 0 0 8 48.189 681.5031 Tm
(17.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(R)40.5 (ecabarren )53.1 (A, )54.6 (Apaza )-0.8 (C, )-0.8 (Castro-R)40.2 (odr\355guez J. Nitrites )-1.8 (in )]TJ
0.124 Tw 0 -1.2 TD
[(induced )-1.9 (sputum )-1.5 (as a )-0.6 (simple )-0.7 (and )-1.1 (cheap )-1.6 (non-invasive )-1.5 (marker )]TJ
-0.009 Tw T*
[(of airway )-1.5 (inflammation )-2.3 (for )0.6 (asthmatic )-2.9 (schoolchildren. )-1.4 ( P)47.2 (ediatr )]TJ
0 Tw T*
(Allergy Immunol. 2008; 19\(5\): 433 \226 7.)Tj
0.198 Tw -1.772 -1.2 Td
(18.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Brouwer )54.6 (A, )-0.6 (R)40.4 (oorda R, )-0.9 (Brand )-1.1 (P)195.7 (. )-0.6 ( )-0.7 (Comparison between )-3 (P)47.3 (eak )]TJ
-0.092 Tw T*
[(Expiratory Flow and )-1.1 (FEV1 )-0.6 (measurements )-2.4 (on a )-0.6 (home )-0.6 (spirometer )]TJ
-0.018 Tw T*
[(and )-1.4 (on a )-0.9 (pneumotachograph )-3 (in )-1 (children )-1.7 (with )-1.7 (asthma. )-2.2 ( P)47.3 (ediatr )]TJ
0 Tw T*
(Pulmonol. 2007; 42\(9\): 813 \226 8.)Tj
0.17 Tw -1.772 -1.2 Td
(19.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Lazo-V)64.2 (el\341sque)-1.4 (z J, Lozada )54.1 (A, )-0.7 (Cruz H. )-1.1 (Evaluation )-1.8 (of severity )]TJ
0.019 Tw T*
[(of bronchial )-1.2 (asthma )-1.9 (through )-1.3 (an )-1.2 (exercise )-1.4 (bronchial )-1.1 (challenge. )317.9 ( )]TJ
0 Tw T*
[(P)47.3 (ediatr Pulmonol. 2005; 40\(5\):457\226 63.)]TJ
0.362 Tw -1.772 -1.2 Td
(20.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Beerthuizen )15.7 (T)166.4 (, V)64.1 (oored-van S, van den )-0.9 (Hout )-0.9 (W)92.3 (, V)78.3 (aessen-)]TJ
-0.043 Tw T*
[(V)64 (erberne )54.4 (A, Bracke)-0.9 (l H, Landstra )53.8 (A, et )-0.6 (al. Cost-effectiveness )-1.3 (of )]TJ
0.099 Tw T*
[(FENO-based )-0.8 (and )-1 (web-based )-1.7 (monitoring )-0.7 (in )-0.7 (paediatric )-2.2 (asthma )]TJ
0.204 Tw T*
[(management: )-3.6 (a )-0.9 (randomised )-1.5 (controlled )-0.8 (trial. )16.8 (Thorax. 2016; )]TJ
0 Tw 0 -1.2 TD
(71\(7\): 607 \226 13.)Tj
0.173 Tw -1.772 -1.2 Td
(21.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(V)64 (oorend-van )-0.8 (Bergen, )-1.3 (V)78.2 (aessen )-1.4 (V)146.1 (, Jongste JC, P)47.2 (ijnemburg )-1.1 (M. )]TJ
0.04 Tw 0 -1.2 TD
[(Asthma )-1.2 (control questionnaires )-2.3 (in )-0.8 (the )-1.4 (management )-3.2 (of )0.6 (asthma )]TJ
0 Tw T*
[(in children: a review)102.3 (. P)46.8 (ed Pulmonol 2015; 50\(2\): 202\2268.)]TJ
0.034 Tw -1.772 -1.2 Td
(22.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Oliveira )-1.2 (S, )-0.8 (Sarria )-0.9 (E, R)40.5 (oncada )-1.8 (C, )-1 (Stein )-2.1 (R, )-0.9 (P)47.3 (itrez )-1 (M, )-1.4 (Matiello )-2 (R. )]TJ
0.163 Tw T*
[(V)78.2 (alidation )-2 (of the )-1.7 (Brazilian )-0.9 (version of the )-1.7 (childhood )-0.8 (asthma )]TJ
0 Tw T*
[(control test \(ACT\). P)45.3 (ed Pulmonol. 2016; 51\(4\): 358 \226 63.)]TJ
-0.072 Tw -1.772 -1.2 Td
(23.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Bussi L, )-0.7 (Sly P)195.7 (, R)40.5 (estuccia )-2 (S, LLanc)-1.6 (am\341n )-1 (L. )-0.6 (V)78.2 (alidation )-1.8 (of )0.7 (a school-)]TJ
0.021 Tw T*
[(based )-0.9 (written )-1.8 (questionnaire )-2.5 (for )1 (asthma )-1.6 (case )-0.7 (identification )-2.8 (in )]TJ
0 Tw T*
[(Argentina. P)44.8 (ed Pulmonol. 2012; 47\(1\): 1 \226 7.)]TJ
0.386 Tw -1.772 -1.2 Td
(24.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Castro-R)40.3 (odr\355guez J, Molina )-1.4 (R, C\341ceres )-1.3 (M, )-1.1 (R)40.5 (ecabarren )53.2 (A. )]TJ
0.109 Tw T*
[(Correlation )-0.7 (between )-2.6 (Nitrites )-1.6 (in )-0.8 (induced )-2 (sputum )-1.5 (and )-1.1 (asthma )]TJ
0.118 Tw T*
[(symptoms )-0.8 (in )-1.3 (asthm)-1.1 (atic )-1.8 (schoolchildren. )-1.6 (P)47.3 (ed )-1.2 (Pulmonol. 2014; )]TJ
0 Tw T*
(49\(3\): 214 \226 20.)Tj
0.052 Tw -1.772 -1.2 Td
(25.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Chinellato )-1.9 (I, )-0.7 (P)47.3 (iazza M, )-0.8 (Sandri )-0.9 (M, Cardinali )-1.6 (F)180.3 (, P)47.3 (eroni G, )-0.7 (Boner )]TJ
0.06 Tw T*
[(A, et )-1.3 (al. )-1 (Evaluation )-1.5 (of association )-1.3 (between )-2.8 (exercise-induced )]TJ
0.043 Tw T*
[(bronchoconstriction )-0.9 (and )-0.9 (childhood asthma )-1.6 (control test )-1.2 (\(ACT\) )]TJ
0.317 Tw T*
[(questionnaire )-2.8 (sco)0.5 (res in )-1 (children. )-1.8 (P)47.3 (ediatr )-1.7 (Pulmono.l 2012; )]TJ
0 Tw T*
(47\(3\): 226 \226 32.)Tj
-0.006 Tw -1.772 -1.2 Td
(26.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(P)47.3 (edersen )-1.1 (S, Hu)-0.7 (rd S, Lemanske )-2.1 (R, Becker )54.3 (A, Zar H, Sly P)195.7 (, et )-0.8 (al. )]TJ
-0.034 Tw T*
[(Global )-0.7 (strategy )-1.7 (for )0.6 (the )-1.7 (diagnosis )-0.8 (and )-1.3 (mangement )-3 (of asthma )-1.9 (in )]TJ
0.051 Tw T*
[(children )-1.2 (5 years and )-1 (younger)132.7 (. P)47.2 (edia)-1.1 (tr Pulmonol. 2011; )-1.8 (46\(1\): )]TJ
0 Tw T*
(1 \226 17.)Tj
-0.019 Tw -1.772 -1.2 Td
(27.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(K)31.6 (oolen B, P)47.3 (ignenburg )-1.1 (M, )-0.9 (Brackel )-1 (H, )-0.7 (Landstra )53.4 (A, V)78.2 (an )-0.9 (den )-1.1 (Bergh )]TJ
0.098 Tw T*
[(N, Merku)-1.4 (s )0.5 (P)195.7 (, et )-0.7 (al. V)78.2 (alidation )-1.4 (of )1 (a web-based )-1.4 (versi\363n )0.5 (of )1 (the )]TJ
-0.046 Tw T*
[(asthma )-1.4 (control test )-1.1 (and )-0.8 (chidhood asthma )-1.3 (control test. )-1.2 (P)47.2 (ediatr )]TJ
0 Tw T*
(Pulmonol. 2011; 46\(10\): 941 \226 8.)Tj
0.015 Tw -1.772 -1.2 Td
(28.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Murray C, Foden )-0.8 (P)195.7 (, Sumner )-0.9 (H, Shepley )-1 (E, Custovic )54.7 (A, Simpson )]TJ
0.29 Tw T*
[(A. P)47.3 (reventing )-2.1 (severe )-0.9 (asthma )-2 (exacerbations )-2.4 (in )-1 (children: )-1.9 (a )]TJ
0.143 Tw T*
[(randomised )-0.8 (trial )-0.6 (of )0.7 (mite )-1.1 (impermeable )-1.9 (bedcovers. )55 (American )]TJ
0 Tw T*
[(Journal R)40.3 (espir Critical Care Medicine. 2017)]TJ
0.16 Tw 29.409 54 Td
(29.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Farber H, Bat)-0.8 (sell R, Silveira E, Calhoun )-1.2 (R, Giardino )54.3 (A. )18 (The )]TJ
0.058 Tw T*
[(impact )-1.1 (of)0.7 ( tobacco smoke exposure on childhood asthma )-1.3 (in a )]TJ
0 Tw T*
(Medicaid managed Care Plan.Chest 2016; 149 \(3\): 721 \226 8. )Tj
0.171 Tw -1.772 -1.2 Td
(30.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Chen )-1.8 (C, )-1 (Chao )-0.6 (H, )-1.1 (Chang )-1.9 (C, )-1 (Chen )-1.9 (B, )-0.8 (Guo )17.2 (Y)160.8 (. )-0.8 (Current )-1.7 (asthma )]TJ
0.175 Tw T*
[(in )-1.2 (schoolchildren )-1.4 (is )-0.6 (related )-2.1 (to )-0.8 (fungal )-1 (spores in )-1.2 (classrooms. )]TJ
0 Tw T*
(Chest. 2014; 146\(1\): 123 \226 34.)Tj
0.098 Tw -1.772 -1.2 Td
(31.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Barrat B, Quin)-0.7 (t J. )55.5 (Asthma )-0.8 (hospit)-0.6 (alizations )-0.8 (and )-0.7 (air pollution. )]TJ
0 Tw T*
(Thorax. 2016; 71\(12\): 1076 \226 7.)Tj
0.326 Tw -1.772 -1.2 Td
(32.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(R)40.5 (ecabarren )53.7 (A, P)47.2 (ortugal K, Gu)-0.7 (ti\351)-1 (rrez )0.8 (J. Comparaci\363n de )]TJ
0.25 Tw T*
[(las )-0.7 (caracter\355sticas)-2.1 ( )-0.6 (cl\355nicas )-1.5 (del )-1.1 (asma )-1.2 (bronquial )-1.3 (entre )-2 (ni\361os )]TJ
0.284 Tw T*
[(con sobr)0.8 (epeso/obesidad )-1.8 (y ni\361os )-0.7 (eutr\363ficos inscritos en )-1.1 (el )]TJ
0.313 Tw T*
[(programa de )-0.9 (asma )-0.7 (bronquial )-1.1 (del )-0.8 (Hospital )-1.1 (III )16.8 (Y)92.4 (anahuara )-2.7 (\226 )]TJ
0 Tw T*
[(EsSalud )54.7 (Arequipa. Diagn\363stico 2003; 42\(2\): 60 \226 7.)]TJ
0.1 Tw -1.772 -1.2 Td
(33.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Bitsko )-0.7 (M, )-0.9 (Ever)0.6 (hart )-1.2 (R, R)28.8 (ubin )-1.3 (B. )17.8 (The )-1 (adolescent )-1.9 (with )-1.4 (asthma. )]TJ
0 Tw T*
[(P)47.3 (aediatr R)38.6 (espir R)40 (ev)134.1 (. 2013; 15\(2\): 146 \226 53. )]TJ
-0.009 Tw -1.772 -1.2 Td
(34.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Jensen )-2 (M, )-1.4 (Collins )-1 (C, )-1 (Gibson )-1.1 (P)195.7 (, )-0.8 (W)45.8 (ood L. )16.9 (The )-1.1 (obesity )-1.4 (phenotype )]TJ
-0.012 Tw T*
[(in children )-1 (with )-1 (asthma. )-1.6 (P)47.3 (aediatr )-1.5 (R)40.5 (espir R)40.5 (ev)134.1 (. 2011; )-1.7 (12\(3\): )-1.7 (152 )]TJ
0 Tw T*
(\226 9.)Tj
0.009 Tw -1.772 -1.2 Td
(35.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Shefer )-1.2 (G, )-1.2 (Donchin )-1.6 (M, )-1.4 (Manor )-1.3 (O, )-0.7 (Levy-Hervroni )-1.2 (R, )-1 (Schechter )52.6 (A, )]TJ
0.127 Tw T*
[(Cohen )-1.1 (H, et )-1 (al. )-0.6 (Disparities )-1.6 (in )-0.6 (assesments )-1.3 (of )0.7 (asthma )-1.7 (control )]TJ
0.05 Tw T*
[(between )-2.6 (children, )-1.6 (parents )-1.5 (and )-1.2 (physicians. )-1.9 (P)47.3 (ediatr )-1.5 (Pulmonol. )]TJ
0 Tw T*
(2014; 49\(10\): 943 \226 51.)Tj
0 1 0.65 0.47 k
/GS0 gs
/TT1 1 Tf
-1.772 -2.5 Td
(Fuentes de financiamiento:)Tj
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
T*
(Este art\355culo ha sido financiado por los autores.)Tj
0 1 0.65 0.47 k
/GS0 gs
/TT1 1 Tf
0 -2.45 TD
(Conflictos de inter\351s:)Tj
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
0 -1.2 TD
(Los autores declaran no tener ning\372n conflicto de inter\351s.)Tj
0 1 0.65 0.47 k
/GS0 gs
/TT1 1 Tf
0 -2.45 TD
(Correspondencia:)Tj
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
0 -1.25 TD
[(Arturo R)40.6 (ecabarren Lozada)]TJ
T*
[(Direcci\363n: Filomena 102. Pueblo V)13.1 (iejo, Cerro Colorado. )]TJ
T*
[(T)124.9 (el\351fono: 959654097)]TJ
T*
(Correo electr\363nico: arturorecabarren@gmail.com)Tj
ET
0 1 0.65 0.47 k
/GS0 gs
330.236 296.306 170.079 36.851 re
f
BT
0 0 0 0 k
9 0 0 9 345.0299 316.9136 Tm
[(R)40.5 (ecibido: 28 de febrero de 2017)]TJ
0 -1.222 TD
(Aprobado: 31 de marzo de 2017)Tj
0 0 0 1 k
/GS1 gs
-13.721 46.879 Td
[(Arturo R)40.5 (ecabarren Lozada, Elvira P)44.7 (arishua\361a Calcina, Nadia Mart\355nez Murillo, )]TJ
23.139 -1.111 Td
(Grimaneza Esqu\355a Moroco)Tj
ET
endstream
endobj
21 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
BT
0 0 0 1 k
/GS0 gs
/TT0 1 Tf
0.04 Tc 0 Tw 0 Ts 100 Tz 0 Tr 9 0 0 9 439.4828 32.9076 Tm
(abril - junio 2017)Tj
ET
endstream
endobj
34 0 obj
<>
endobj
35 0 obj
<>
endobj
36 0 obj
<>stream
H\ϊ0y9T)Plh2vk1=;qJ6%}dF&|j1`8Owz+QqZj윐dn9ae slNzq+荽n ۻs?8
@UƁtj5&,;)>甋Qu
}go(ʄVV%~PߝeIBL}ߧi9\09kYGM~d>F>1"u%/S<Ł>Q}|MSwm~Ni'~ ZU
endstream
endobj
37 0 obj
<>stream
HU TsDA@{1LQqP'@F8D*C
҆+Ds*!!rԴlPE}Zz>|{l0lxGW6KpbrVwq` ɓsS݁ZR5=(SzqSڮ4xHMJ9A懶g:~?dd测_K@IB|EtkVRFI@zwD/YO̵\qkNbKLb.W}FfuW]rw1)i wPX@
3 ^piێ :'&]p(RIMR˵{<{6hfKP͚x 4ex[iۮCHG;wڭ{dTtzۯbX\#FJHLԴ1cefeNș;iӦϘ9+<`K.{bO>tϮZx^K[^ʫƶ7ھw}w⣏?]g8x3#Glj*W.p,s%ڭYBSP=A_OdxFa1BVFlDVchl6ub14(` <`$ZR_|0uv3n5>,|̴AVW-$}4pvhhN,oc5
N,;2&/K`rn>0;R~5)r#O8ڮMve^]\ݮfTTU],\u2zmZR֨
2O=uV削¹**+Z*_q׃kp&B6fG2+'Ryu1R榰0l"Xx/a#'q ?c!P[~+xHHE a?[03t\
c1㐅LdccDLB.&c
Ca*c&f`Ys.q=X&j'XΓzkX*~j֧7}ox6ygy;~x?'^7^5^lA 6ר}_
dc%W2)MEբA3JPJ&f*7NR,|@Q<0dQj(wي5Ϊ pB^qbgvaodك1^>~A`PxpHbLf
StfXf2O+'0I)TNtL:nٜù,ڲ{r ?<
\[؎TlÛsTkZ#>~-Pk7T+YmV*\.lR>T#H o.og;FWARҗ=2Ri䫡V%k/ƶ8Q$>5NjyOff2ɶ_+],>nA6#:*{]:?鑎wx}6-B7 4V۵h$h!A11a=(IIwK1ESb$:=#35=itBP#*(dఁq"/7J.8NYq*2Èˈ4JhDDO(JJݺuOuE"4Yg:,ccr_5Q$W{~m[2aahxKXm`"JQAc)րCv("N(*l`)B'߫16)z꽯UK=S(/ȱq0dڶh,lX^ƕ-̮Y/Rb|֕zJ^#'!Oz1EWdN \F3)5|µ2UK~ި~-/\6Dq)=iq/hqbTvϸR2(o)ǔ0ۦ];lYw[yR+&4qMΦzI U+j
R[Fߒz4_YoyCCAJ\0j _.!(Kb0 ^tJ&_KZ0D~Y48Hĸ5>ۇa'|gpNR2 skvO@rǦʘjanH7iLR!" `'0%\Ϛb%6;m~X:M۳s\2Cb aӧ`HC{֞FF9dl
i0H^Z+'!g̥QU~G'Ydy8N ^FG?gYŤ{T66 )wf+Z~N6G5X|yiw{|iЫ} @#z(Ŀ@3-:4 /ԘSh' D&Xʞ*DTb
`~q\Kф}Lv pa8o,M[ZuϟKxshYTe@2[N&z15Ɩyϴ+9S;IO 䓲Z)KH4dhEC**ZY&ȨUOz9ԽmِlXl`3